---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-063899"
form_type: "8-K"
ticker: "RIGL"
cik: "0001034842"
company_name: "RIGEL PHARMACEUTICALS INC"
filed_at: "2022-05-23T23:59:59+00:00"
generated_at: "2026-06-25T07:57:27.883356+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Rigel stockholders approve 2018 Equity Plan amendment adding 5M shares

## Summary
- Amended 2018 Equity Incentive Plan increases authorized shares by 5,000,000, effective immediately after stockholder approval on May 19, 2022.
- Vote on amendment: 72,954,216 for, 47,859,509 against, 1,366,196 abstain, 19,065,889 broker non-votes.
- Stockholders elected directors Kamil Ali-Jackson and Jane Wasman to terms expiring at 2025 annual meeting.
- Say-on-pay advisory vote approved: 113,344,916 for, 7,265,856 against, 1,569,149 abstain.
- Ernst & Young ratified as independent auditor for FY2022: 133,170,094 for, 7,845,051 against, 230,665 abstain.

## SEC filing metadata
- accession: 0001104659-22-063899
- form_type: 8-K
- ticker: RIGL
- cik: 0001034842
- company_name: RIGEL PHARMACEUTICALS INC
- filed_at: 2022-05-23T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1034842/000110465922063899/0001104659-22-063899-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1034842/000110465922063899/tm2216206d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-063899
- JSON: https://secwatch.observer/filing/0001104659-22-063899.json
- Plain text: https://secwatch.observer/filing/0001104659-22-063899.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.